Stock 42C IX BIOPHARMA LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company iX Biopharma Ltd.

Equities

42C

SG1BD9000009

Pharmaceuticals

Market Closed - Singapore S.E.
Other stock markets
 03:14:38 2024-04-26 am EDT 		5-day change 1st Jan Change
0.042 SGD +2.44% Intraday chart for iX Biopharma Ltd. +5.00% -6.67%
Mar. 12 Singaporean Shares End Marginally Higher; Biopharma's Shares Climb 2% on Introduction of New Sublingual Wafer MT
Mar. 12 IX Biopharma Introduces New Sublingual Wafer MT

Business Summary

IX Biopharma Ltd. is a Singapore-based specialty pharmaceutical and nutraceutical company. The Company is focused on the development, manufacturing and commercialization of innovative therapies for the treatment of acute and breakthrough pain, and other health conditions. It has developed a patented drug delivery platform technology, WaferiX. WaferiX is a novel multi-drug delivery platform comprising a highly porous, amorphous and non-ionic matrix in a solid dosage form. The Company operates through two segments: Specialty Pharmaceutical and Nutraceutical segments. Specialty Pharmaceutical primary business activities are the development, manufacturing and sale of pharmaceutical and medicinal cannabis products. Nutraceutical primary business activities are the sale of nutraceutical products. The Company's pipeline of products under development includes Wafermine (ketamine wafer) and BnoX (buprenorphine wafer) for pain management.

Number of employees: 45

Sales per Business

SGD in Million2022Weight2023Weight Delta
Specialty Pharmaceutical
87.3 %
14 95.7 % 5 87.3 % -62.51%
Nutraceutical
12.7 %
1 4.3 % 1 12.7 % +21.39%

Sales per region

SGD in Million2022Weight2023Weight Delta
Australia
86.6 %
1 9.5 % 5 86.6 % +273.05%
China
9.8 %
1 3.6 % 1 9.8 % +11.13%
Singapore
2.0 %
0 0.6 % 0 2.0 % +25.81%
United States
1.6 %
12 86.2 % 0 1.6 % -99.23%

Managers

Managers TitleAgeSince
Yip Hang Lee CEO
 Chief Executive Officer - 04-05-07
Sien Lup Chew DFI
 Director of Finance/CFO 60 16-04-13
Janakan Krishnarajah COO
 Chief Operating Officer 45 16-03-31
Iain Cook CTO
 Chief Tech/Sci/R&D Officer - 15-09-24
Stephen Lim PRN
 Corporate Officer/Principal - -
Kuan Loong Lai SEC
 Corporate Secretary 45 -
Soo Fern Lee SEC
 Corporate Secretary - -

Members of the board

Members of the board TitleAgeSince
Yip Hang Lee CEO
 Chief Executive Officer - 04-05-07
Shing Tung Ho BRD
 Director/Board Member 57 13-02-28
Patrick Davies BRD
 Director/Board Member 57 19-12-01
Woon Keng Teo BRD
 Director/Board Member 67 22-11-06
Xi Wen Tham BRD
 Director/Board Member - 22-01-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 768,317,356 376,567,123 ( 49.01 %) 0 49.01 %

Shareholders

NameEquities%Valuation
Yip Hang Lee
23.15 %
177,869,551 23.15 % 7 M $
Bee Lee Puah
8.688 %
66,748,029 8.688 % 3 M $
Singh Narulla Jaspal
3.998 %
30,718,383 3.998 % 1 M $
Choy Leng Tang
2.432 %
18,683,250 2.432 % 719 866 $
Hwee Hoon Chan
1.674 %
12,861,113 1.674 % 495 539 $
Boon Lock Seah
1.504 %
11,553,869 1.504 % 445 171 $
Shing Tung Ho
1.206 %
9,266,705 1.206 % 357 046 $
Mohan Mulani
1.083 %
8,318,000 1.083 % 320 493 $
Wee Liat Yeoh
0.7884 %
6,057,473 0.7884 % 233 394 $
Qin Quan Seah
0.7113 %
5,465,238 0.7113 % 210 576 $

Company contact information

iX Biopharma Ltd.

Great World City East Tower 1 Kim Seng Promenade

237994, Singapore

+

http://www.ixbiopharma.com
address iX Biopharma Ltd.(42C)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
IX BIOPHARMA LTD. Stock iX Biopharma Ltd.
-6.67% 23.16M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+24.35% 653B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+25.34% 556B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.33% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.90% 331B
ABBVIE INC. Stock AbbVie Inc.
+7.95% 296B
ASTRAZENECA PLC Stock AstraZeneca PLC
+12.83% 233B
NOVARTIS AG Stock Novartis AG
+5.27% 201B
ROCHE HOLDING AG Stock Roche Holding AG
-9.86% 193B
AMGEN INC. Stock Amgen Inc.
-6.47% 144B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 42C Stock
  4. Company iX Biopharma Ltd.